scispace - formally typeset
M

Michael O. Woods

Researcher at Memorial University of Newfoundland

Publications -  113
Citations -  5356

Michael O. Woods is an academic researcher from Memorial University of Newfoundland. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 35, co-authored 98 publications receiving 4205 citations. Previous affiliations of Michael O. Woods include BC Cancer Agency & St. John's University.

Papers
More filters
Journal ArticleDOI

Improving the stability of 11C–labeled L-methionine with ascorbate

TL;DR: To minimize oxidation, ascorbate was added to the HPLC eluant, and the resulting HPLC-purified 11C–MET was stable in the final formulation solution without noticeable degradation for up to 1 h after the end of synthesis.
Journal ArticleDOI

Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk.

Zhiyu Xia, +59 more
- 24 Mar 2020 - 
TL;DR: Body mass index (BMI) and diabetes are established risk factors for colorectal cancer (CRC), likely through perturbations in metabolic traits (e.g. insulin resistance and glucose homeostasis).
Journal ArticleDOI

Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

Xia Jiang, +395 more
TL;DR: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Journal ArticleDOI

A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer.

Aayah Nounu, +78 more
TL;DR: In this article, the authors combined a proteomic approach with Mendelian randomization (MR) to identify possible new aspirin targets that decrease colorectal cancer (CRC) risk.
Posted ContentDOI

A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer

Aayah Nounu, +78 more
- 14 Aug 2020 - 
TL;DR: MCM6 and RRM2 are involved in DNA repair whereby reduced expression may lead to increased DNA aberrations and ultimately cancer cell death, whereas ARFIP2 is involved in actin cytoskeletal regulation indicating a possible role in aspirin’s reduction of metastasis.